IP Library Granted Patent US 10,390,954
Granted Patent B2
US 10,390,954 · App. 15/288,328 · Granted Aug 27, 2019

Method to introduce an implantable device to fill a bone void whilst minimising pressurisation

Inventors: John Warren Colclough (Keele, GB); Phillip Anthony Laycock (Keele, GB); John Joseph Cooper (Keele, GB); Russell David Waters (Keele, GB)
Assignee: BIOCOMPOSITES LIMITED
A61F2/28A61B17/7283A61B17/921A61F2/44A61F2/4644A61L27/025A61L27/12A61L27/54A61M37/0069B29C39/026B33Y80/00A61F2002/2835A61F2002/2839A61F2250/0067A61L2300/404A61L2300/414A61L2300/416A61L2430/02B29L2031/7532
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,390,954
App. No.
15/288,328
Granted
Aug 27, 2019
Kind
B2
Abstract

Disclosed is an invention that provides a method of treating a bone void of a patient through the use of an implantable device whilst minimising the potential for an increase in pressure within the bone void thus avoiding embolization of the void contents into the patient's bloodstream.

Claims (18)

1. A method of reconstructing a bone void in a patient, the method comprising introducing into a bone void of one or more implantable devices, each of which one or more implantable devices are substantially cylindrical, having a convex, domed or semi-spherical shaped ends; contain one or more longitudinal channels where the one or more longitudinal channels create a venting path allowing for depressurisation of any contents of the bone void, the one or more longitudinal channels each intersecting a surface of the device and extending towards an axial centerline thereof, and being tapered such that the width of the one or more longitudinal channels opening on an outer, circumferential edge of the implantable device is greater than its width at a base thereof; and have a flat surface on an opposing longitudinal side to the one or more longitudinal channels;

whereby introduction of the one or more implantable devices reconstructs bone in the bone void in the patient.

2. The method of claim 1 where the one or more implantable devices comprise a hardened bone substitute material.

3. The method of claim 1 where the bone void is a contained bone void.

4. A method of claim 2 where the one or more implantable devices are moulded through the use of a multi-cavity flexible mould mat or by 3D printing.

5. A method of claim 1 where the one or more implantable devices are inserted into the bone void by being digitally packed.

6. A method of claim 1 where the one or more implantable devices are inserted into a bone void by the use of an introducer comprising a guide tube and a pusher.

7. A method according to claim 1 where the bone void is a long bone intramedullary canal of a patient.

8. A method according to claim 7 where the bone void is a long bone medullary canal that is reamed out to a diameter to slidingly accept the one or more implantable devices or the guide tube.

9. A method according to claim 7 where the bone void is debrided prior to insertion of the one or more implantable devices.

10. A method according to claim 1 where the one or more implantable devices contains a medicament.

11. A method according to claim 10 where the medicament is an antimicrobial intended to prevent or treat an infection.

12. A method according to claim 11 where the infection is bacterial, fungal or parasitic.

13. A method according to claim 10 where the medicament is an antineoplastic agent for treating a bone tumour, such as a giant cell tumour of bone.

14. A method according to claim 10 where the medicament is a bone morphogenetic protein to aid in bone regeneration.

15. A method of reconstructing a bone void in a patient while reducing pressurisation of the bone void, the method comprising introducing into a bone void of one or more implantable devices through the use of a guide tube and a pusher that facilitates the one or more implantable devices being freely inserted into the intramedullary canal; where the one or more implantable devices comprise: 1) a capsule shape, having convex, domed or semispherical shaped ends; and 2) one or more longitudinal channels extending the entire length of the implantable device;

wherein the one or more longitudinal channels create a venting path allowing for the depressurization of any contents of the bone void, the one or more longitudinal channels each intersecting a surface of the device and extending towards an axial centerline thereof, and being tapered such that the width of the one or more longitudinal channels opening on an outer, circumferential edge of the implantable device is greater than its width at a base thereof, and have a flat surface on an opposing longitudinal side to the one or more longitudinal channels;

whereby introduction of the one or more implantable devices reconstructs bone in the bone void while reducing pressurisation of the bone void in the patient.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jun 14, 2022
From: BARINGS FINANCE LLC
To: BIOCOMPOSITES LIMITED
Reel/Frame 060191/0602 →
SECURITY INTEREST Recorded Jun 1, 2017
From: BIOCOMPOSITES LIMITED
To: BARINGS FINANCE LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 042648/0808 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2016
From: COLCLOUGH, JOHN WARREN; LAYCOCK, PHILLIP ANTHONY; WATERS, RUSSELL DAVID; COOPER, JOHN JOSEPH
To: BIOCOMPOSITES LIMITED
Reel/Frame 039966/0865 →
Priority Claims (1)
GB 1502655.2 · Feb 17, 2015 · national
Continuity (2)
Continuation In Part 15040075 · Feb 10, 2016
Related Publication 20170020673A1 · Jan 26, 2017